Browse By: Country ι Category ι Latest Reports ι Tag

Non-public hospitals market in Central Europe 2013

Pages » 186
Published By » PMR
Price » $3500
In stock
View Report Details
Description

Growth in the market for non-public hospitals in the Central European countries of Bulgaria, the Czech Republic, Hungary, Poland, Romania and Slovakia has been curtailed, to a degree, by lack of ability to spend large amounts on private healthcare in these six countries. Populations more commonly use public healthcare systems, but the affluent are increasingly turning to private hospitals in order to take advantage of faster service and higher quality care.  Changes in the field of healthcare, combined with advancing economies, have prepared the private sector for potential growth that was unexpected until recently. Non-public hospitals market in Central Europe 2013, Comparative an... Click here for more details


Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers t
Published Date: Oct 2010
Price: $3500
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market
GBI Research’s pharmaceuticals report, “Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis
Published Date: Sep 2010
Price: $3500
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
GBI Research’s new report, “Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics
Published Date: Oct 2010
Price: $3500
Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
GBI Research, the leading business intelligence provider, has released its latest report, “Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issu
Published Date: Dec 2010
Price: $3500
Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions” that provides key data, information and analy
Published Date: Dec 2010
Price: $3500
Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market
GBI Research, the leading business intelligence provider, has released its latest research “Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market” which provides insight about contraceptive sales and price for
Published Date: Dec 2010
Price: $3500
Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential
GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in India to 2017 - Limited Patient Affordability for High Priced Biologics Lowers Market Potential”, which provides insights into oncology sales and price forecasts until 2017
Published Date: Dec 2010
Price: $3500
Seasonal Influenza Vaccine Market in Asia - Pacific Region - Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth
GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific Region-Threat of Pandemic Influenza and Increasing Vaccination Coverage to Drive Growth” which essentially provides insights on seasonal influenz
Published Date: Jan 2011
Price: $3500
Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
GBI Research, the leading business intelligence provider, has released its latest research, Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market, which provides insights into oncology sales and price fore
Published Date: Jan 2011
Price: $3500
Targeted Therapeutics - Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
GBI Research, the leading business intelligence provider, has released its latest research Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market. The report provides in-depth analysis of the major targeted therapeutics. The Market Drivers and Restraints f
Published Date: Feb 2011
Price: $3500

 


 

Related News

Upfront Payout of US$65 Million for Isis Pharma
Isis Pharmaceuticals continues to expand into multiple disease sectors, in which the latest move includes the signing of a top level drug development partnership with another drug company. The new partnership with AstraZeneca will get US$65 million to Carlsbad biotech upfront. The deal also calls for Isis Pharma to discover and work on drugs that are useful in cardiovascular, kidney, and metabolic diseases. They are to develop these drugs using the antisense technology developed by Isis. I
Date: Aug 03

16.59% Rally of China Pharma Holdings’ Shares
China Pharma Holdings, Inc. company shares rose by 16.59% in the previous week. The pharma company still tallied to a loss of 23.53% during the past four weeks. The company share did surpass the S&P 500 in the previous week by 15.25%. However, they have underperformed the index by 24.51% within the last four weeks. China Pharma Holdings, Inc. shares have slowed down by 29.73% within the previous three month period. The current year-on-year performance is -13.36%. The company shares
Date: Aug 03

Japan Promotes Higher Education to Improve the Skills of the Graduates
Shinzo Abe, the Prime Minister of Japan, is aiming to develop better-skilled graduates by retooling the public universities. The main motto is to transform the government-funded universities of Japan into scientific research centers, schools or global leaders. Japan’s Universities are planning to achieve this target by restructuring the curricula and redefining the missions. In June, all 86 of Japan’s national level universities were asked to submit their refined plans by the educ
Date: Aug 03

Hong Kong Ranked Fourth Amongst the 148 Most Popular Arbitral Venues
Cross-border investments, in the recent past, led to complex relations amongst the commercial parties. Commercial parties are moreover depending on the international arbitration to solve respective disputes. Hong Kong, for many reasons, is considered to be the most attractive arbitral venue in Asia Pacific.  As per the World Economic Forum Global Competitiveness Report, published for year 2013-2014, Hong Kong is ranked fourth amongst the 148 jurisdictions. Hong Kong is supposedly ahead o
Date: Aug 03

Slump in Oil and Gas Industry Taking Toll on Industry Economy
As the shippers, drivers, and airlines maintain to enjoy the lower fuel prices, the oil industry is broadly responding to extremely lower profits with high cuts in employment and spending. These cuts are affecting the economic growth.    Low gas and oil prices are beneficial for the overall economy. They help to reduce the costs for business and consumers. As the U.S. economic growth was extremely higher in the second quarter, the economists express that was partially boosted by the
Date: Aug 03

JX Holdings’ Sets its Summer Agenda toward Uproar in Oil Industry
The competition between companies in the global market is becoming more and more intense, day by day. The competition is growing both in domestic and overseas markets.  Yomiuri Shimbun, staff writer requested new leaders about their agenda for this summer. These leaders who took office at the top of the various companies this year were informed about the same.  Of all the companies, the star performer has reached the top and taken the stage. President Yukio Uchida, JX Holdings In
Date: Aug 03

HSBC Reports 10% Increase in Profit for 1st Half of 2015
HSBC Holdings has reported a rise in its profit for the first-half of 2015 by 10%. In a press note issued of Aug 03, 2015, the biggest bank in Europe has stated that the robust performance has helped the company to boost its revenue. In the same note, the bank has also announced the sale of its Brazilian unit for US$5.2 billion. The profit for H1 of 2015 has increased to 48 cents per share, summing up to US$13.6 billion in a whole, stated the bank. The revenue of the bank has increased by 4%
Date: Aug 03

China Plan to Tighten Regulations to Control Online Payment
China has plans to tighten the regulations that governs the country’s 270 online-payment enterprises such as Alibaba. This move has come as another blow to the flourishing Internet business for finance. Under the draft rules issued on July 31, 2015, the central bank is likely to limit the amount that a person can pay online through a third-party payment account to US$805 per day, crossing which, the customer would need to verify his/her identity via an electronic signature and security
Date: Aug 03

Walmart to Further Invest in E-commerce Business in China
The e-commerce market of China has not been a very easy one for Walmart to crack into, however the American retail giant is in no way giving in. On the contrary, Walmart has begun investing a lot more towards the e-commerce operations that it had initiated there, and in a way has taken total control of a particular China-based online retailer.  Walmart, on Thursday ended up purchasing the leftover shares of the Chinese company called Yihaodian. This was after it was seen that Walmart was
Date: Jul 31

Inflatable Device to Help Obese Patients Lose Weight gets FDA Approval
The United States Food and Drug Administration has given its approval for an inflatable device that can help patients suffering from obesity shed their weight without any surgeries. The balloon, made by Reshape Medical, will be inserted inside the body and fill a portion of the stomach.  A minimally invasive endoscopic procedure will be performed by doctors, where in they will go in through the mouth to reach the stomach and implant the device. Typically, the procedure will take less tha
Date: Jul 31

Upcoming Reports

Global Radiotherapy Market (Products & Applications) - Global Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018
Radiotherapy is a treatment for cancer which uses beams of high energy radiation to kill cancer tissues in the body. This therapy stops cancer cells from multiplying. Also called radiation therapy, radiotherapy is emerging as a major technology for killing the cancer disease. The global radiot
Published By: Transparency
Price: $4795
Cancer Therapeutics And Biotherapeutics Market- Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
Cancer is affecting about more than 10 million people every year globally and this number is expected to increase by 2.4% by the year 2020 and reach to 14 million. Biotherapy is one of the most promising and new approach in treatment of cancer as it enhances the natural tendency of body to defend
Published By: Transparency
Price: $4795
Occult Blood Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast, 2012 - 2018
Occult blood testing is carried out to test for the presence of microscopic or invisible blood cells in the stool. It is a type of colorectal cancer screening test. Occult blood is the sign of a problem in the digestive system, which can be a polyp, growth, or a cancer in the rectum or colon. Once
Published By: Transparency
Price: $4595
Nanomedical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Factors such as rising prevalence of chronic medical conditions in the fields of neurosciences and cardiology, increasing research and development initiatives in the healthcare sector, and technological advancements in the field of medical sciences are responsible for the growth of this market.
Published By: Transparency
Price: $4595
Testosterone Replacement Therapy (TRT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
The testosterone replacement therapy is a process of giving testosterone when testes do not produce sufficient amount of testosterone because of injury, damage or absence. The testosterone replacement therapy has gained the momentum in last decade with high penetration in surgery market. The tes
Published By: Transparency
Price: $4795
Uterine Cancer Therapies and Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Uterine cancer is a cancer of uterus and is classified into the following four types, namely uterine sarcomas, endometrial cancer, cervical cancer and gestational trophoblastic disease. These cancers arise from malignancies of connective tissues, endometrium and cervix uteri of the uterus. Uterine
Published By: Transparency
Price: $4795
Nucleic Acid Aptamers (Diagnostics and Therapeutics) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
Nucleic acid aptamers are species of nucleic acid that are engineered in in vitro selection or SELEX i.e. systematic evolution of ligands by exponential enrichment. Aptamers bind different molecular targets such as proteins, nucleic acids, cells, organisms and other molecules and assist in molecul
Published By: Transparency
Price: $4795
Cardiac Resynchronization Therapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Cardiac resynchronization therapy (CRT) devices are intended to treat heart failure. These devices aid in the proper synchronization of heart beats by sending small undetectable signals to lower chambers of the heart. This in turn enables the heart to pump blood and oxygen more efficiently. This i
Published By: Transparency
Price: $4795
Rheumatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
With increasing joint and connective tissue problems caused by hectic lifestyles, non-nutritious food habits, and lack of physical workouts, the demand for rheumatology is on an increase on a global scale. Rheumatology is concerned with the therapy of rheumatic diseases and problems involving join
Published By: Transparency
Price: $4795
Compression Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Compression therapy is a process of applying external pressure to treat various chronic wounds such as deep venous thrombosis, phlebitis and lymphedema. A common myth prevailing among people is that compression bandages and clothes hinder the blood circulation but in reality these products are desig
Published By: Transparency
Price: $4795